drugset / Trial / NCT05972733
Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this trial is to obtain serum for proficiency testing to confirm assay validity is maintained following the dosing of adults with a pediatric dose of HIL-214.
Timeline
- Start
- 2023-08-01
- Primary completion
- 2023-08-14
- Completion
- 2023-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HIL-214 | Vaccine | — | Intramuscular |